VARETTONI, MARZIA
 Distribuzione geografica
Continente #
NA - Nord America 310
EU - Europa 183
AS - Asia 97
Continente sconosciuto - Info sul continente non disponibili 1
Totale 591
Nazione #
US - Stati Uniti d'America 305
IE - Irlanda 108
CN - Cina 73
FI - Finlandia 25
SG - Singapore 18
IT - Italia 17
SE - Svezia 11
DE - Germania 9
CA - Canada 5
BE - Belgio 4
GB - Regno Unito 4
IN - India 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
RU - Federazione Russa 1
Totale 591
Città #
Dublin 108
Chandler 78
Boardman 33
Ashburn 31
Helsinki 23
Shanghai 15
Lawrence 14
Princeton 14
Wilmington 13
Singapore 12
Medford 11
Nanjing 11
Beijing 9
New York 8
Ann Arbor 7
Shenyang 6
Jacksonville 5
Los Angeles 5
Seattle 5
Brussels 4
Hebei 4
Nanchang 4
Pune 3
Washington 3
Brossard 2
Casatenovo 2
Changsha 2
Chicago 2
Falkenstein 2
Hangzhou 2
Induno Olona 2
Jiaxing 2
London 2
Norwalk 2
Paratico 2
Pavia 2
Redwood City 2
Woodbridge 2
Altoona 1
Baoding 1
Berlin 1
Cangzhou 1
Chengdu 1
Clifton 1
Fairfield 1
Guangzhou 1
Houston 1
Longyan 1
Montreal 1
Novokuznetsk 1
Ottawa 1
Prague 1
San Francisco 1
Santa Clara 1
Selangor 1
Shijiazhuang 1
Tianjin 1
Tokyo 1
Toronto 1
Wuhan 1
Xiangtan 1
Zhengzhou 1
Totale 478
Nome #
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 51
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 50
Bing-Neel syndrome: Illustrative cases and comprehensive review of the literature 49
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 48
A revised international prognostic score system for Waldenstrom's macroglobulinemia 45
Recommendations for the diagnosis and initial evaluation of patients with Waldenstrom Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenstrom Macroglobulinaemia 44
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders 44
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 41
Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN 40
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network 38
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis 37
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network 35
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study 34
MYD88 mutated and wild-type waldenström’s macroglobulinemia: Characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4 29
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis 26
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study 7
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study 6
Totale 624
Categoria #
all - tutte 4.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 1 7 2
2020/202150 0 0 1 1 1 14 3 10 15 1 1 3
2021/202266 1 0 1 0 3 6 1 4 3 4 9 34
2022/2023241 21 30 1 8 14 24 0 6 121 3 8 5
2023/2024153 18 28 6 4 5 37 2 13 1 4 15 20
2024/202563 9 19 5 10 9 11 0 0 0 0 0 0
Totale 624